PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
14533983-6	2003	A more common transition involving a valine to isoleucine switch in transmembrane domain I of CCR2B (64I), with unknown functional consequences, was found to delay disease progression but not to reduce infection risk.	Isoleucine	47-57	C-C motif chemokine receptor 2	Homo sapiens	94-99	
22041342-3	2011	The polymorphism, CCR2-V64I, changes valine 64 of CCR2 to isoleucine.	Isoleucine	58-68	C-C motif chemokine receptor 2	Homo sapiens	18-22	
22041342-3	2011	The polymorphism, CCR2-V64I, changes valine 64 of CCR2 to isoleucine.	Isoleucine	58-68	C-C motif chemokine receptor 2	Homo sapiens	50-54	
12853162-1	2003	Examining an association between myocardial infarction (MI) and the Val/Ile polymorphism in the gene for CC chemokine receptor (CCR)2 at the position 64 (CCR2-V64I), 122 MI Czech patients and 277 unrelated control (C) subjects were genotyped by PCR-SSP.	Isoleucine	72-75	C-C motif chemokine receptor 2	Homo sapiens	105-133	
12853162-1	2003	Examining an association between myocardial infarction (MI) and the Val/Ile polymorphism in the gene for CC chemokine receptor (CCR)2 at the position 64 (CCR2-V64I), 122 MI Czech patients and 277 unrelated control (C) subjects were genotyped by PCR-SSP.	Isoleucine	72-75	C-C motif chemokine receptor 2	Homo sapiens	154-158	
12426226-2	2002	A common polymorphism in the human CCR2 gene resulting in a substitution of isoleucine for valine (Val64Ile) has been associated with other disease phenotypes in humans.	Isoleucine	76-86	C-C motif chemokine receptor 2	Homo sapiens	35-39	
11898620-2	2002	Allelic frequency of the first mutation, CCR2-64I, causing the substitution of valine with isoleucine in the CCR2 chemokine receptor, was 0.1106 (95% confidence interval, 0.0714-0.1498).	Isoleucine	91-101	C-C motif chemokine receptor 2	Homo sapiens	41-45	
11898620-2	2002	Allelic frequency of the first mutation, CCR2-64I, causing the substitution of valine with isoleucine in the CCR2 chemokine receptor, was 0.1106 (95% confidence interval, 0.0714-0.1498).	Isoleucine	91-101	C-C motif chemokine receptor 2	Homo sapiens	109-113	
10988120-3	2000	We have, therefore, analyzed polymorphisms of CCR5 (32-bp deletion in CCR5 gene [Delta32]) and of CCR2 (replacement of valine by isoleucine in CCR2 gene [64I]) in 66 Czech patients with sarcoidosis in comparison with a representative sample of Czech normal population.	Isoleucine	129-139	C-C motif chemokine receptor 2	Homo sapiens	143-147	
10780710-2	2000	The CCR2-64I genetic variant [a G to A substitution resulting in a valine (V) to isoleucine (I) change at position 64] is in strong linkage disequilibrium with a mutation within the CCR5 regulatory region (CCR5-59653T).	Isoleucine	81-91	C-C motif chemokine receptor 2	Homo sapiens	4-8	
10351956-3	1999	A transition causing a valine to isoleucine substitution in transmembrane domain I of the CCR2 gene (CCR2-64I) that has a protective effect against the progression of human immunodeficiency virus-1 (HIV-1) disease has been described.	Isoleucine	33-43	C-C motif chemokine receptor 2	Homo sapiens	90-94	
10351956-3	1999	A transition causing a valine to isoleucine substitution in transmembrane domain I of the CCR2 gene (CCR2-64I) that has a protective effect against the progression of human immunodeficiency virus-1 (HIV-1) disease has been described.	Isoleucine	33-43	C-C motif chemokine receptor 2	Homo sapiens	101-105	
9815240-1	1998	The effect of a valine to isoleucine switch in the CCR2 first transmembrane domain (CCR2 64I) on the clinical course of human immunodeficiency virus type 1 (HIV-1) infection was analyzed in relation to the presence or absence of syncytium-inducing (SI) HIV-1 variants.	Isoleucine	26-36	C-C motif chemokine receptor 2	Homo sapiens	51-55	
9971830-2	1999	The polymorphism, CCR2-64I, changes valine 64 of CCR2 to isoleucine.	Isoleucine	57-67	C-C motif chemokine receptor 2	Homo sapiens	18-22	
9971830-2	1999	The polymorphism, CCR2-64I, changes valine 64 of CCR2 to isoleucine.	Isoleucine	57-67	C-C motif chemokine receptor 2	Homo sapiens	49-53	
9815240-1	1998	The effect of a valine to isoleucine switch in the CCR2 first transmembrane domain (CCR2 64I) on the clinical course of human immunodeficiency virus type 1 (HIV-1) infection was analyzed in relation to the presence or absence of syncytium-inducing (SI) HIV-1 variants.	Isoleucine	26-36	C-C motif chemokine receptor 2	Homo sapiens	84-88	
9334732-6	1997	A more commonly distributed transition causing a valine to isoleucine switch in transmembrane domain I of CCR2B (64I) with unknown functional consequences was recently shown to delay disease progression but not reduce infection risk.	Isoleucine	59-69	C-C motif chemokine receptor 2	Homo sapiens	106-111